Recent News for ABCL - AbCellera Biologics Inc.

Date Title
Feb 24 The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Feb 17 AbCellera to Present at the SVB Leerink Global Healthcare Conference
Feb 11 AbCellera Biologics picks internal candidate for CTO
Feb 11 AbCellera Appoints Ester Falconer, Ph.D., as Chief Technology Officer
Feb 10 IPO Stock AbCellera Nears Breakout After Lilly-Partnered Covid Drug Nabs OK
Feb 10 AbCellera shares jump after bamlanivimab combo nabs FDA's EUA for COVID-19 treatment
Feb 10 AbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Receives FDA Emergency Use Authorization for COVID-19
Feb 3 AbCellera Announces Date of Fourth Quarter 2020 Financial Results Conference Call
Jan 27 AbCellera-Discovered Antibody, Bamlanivimab, to be Developed with VIR-7831 for the Treatment of COVID-19
Jan 26 AbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Reduced Risk of COVID-19 Hospitalizations and Death by 70%
Jan 21 AbCellera-Discovered Antibody Prevented COVID-19 in Nursing Homes and Reduced Risks by up to 80% for Residents
Jan 19 AbCellera Granted U.S. Patent Covering its Trianni Mouse® Technology
Jan 12 The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
Jan 7 The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
Jan 5 2020 Canadian IPO mixed results - number (77) down, amount ($5.55B) up driven by PE-backed IPOs
Dec 30 The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data
Dec 29 The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
Dec 29 Peter Thiel reports 5.3% stake in AbCellera Bio
Dec 21 AbCellera-Discovered Neutralizing Antibody for COVID-19 Enters New Pragmatic Study in New Mexico
Dec 17 The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
Dec 16 The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
Dec 16 AbCellera Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Dec 11 Certara IPO Soars 66%. Employees Will Get Shares.
Dec 11 AbCellera Rockets 260%, 4D Molecular Up 92% as Flurry of Health-Care IPOs Begin Trading
Dec 11 COVID-19 antibody therapy developer AbCellera Bio prices IPO above range at $20
Back to the Main ABCL Page...